As of January 22, 2025, Pyxis Oncology (PYXS) has a market cap of $92.766 million USD. According to our data, Pyxis Oncology is ranked No.7743 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $92.77 M |
-0.00%
|
Dec 31, 2024 | $92.77 M |
-13.33%
|
Dec 29, 2023 | $0.11 B |
34.33%
|
Dec 30, 2022 | $79.68 M |
-87.78%
|
Dec 31, 2021 | $0.65 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
USA
|
Market Cap | = | PYXS Stock Price | * | PYXS Shares Outstanding |
= | $1.56 | * | 59.47 M | |
= | $92.77 M |